Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 202090
Company: HIKMA
Company: HIKMA
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| SODIUM OXYBATE | SODIUM OXYBATE | 0.5GM/ML | SOLUTION;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 01/17/2017 | ORIG-1 | Approval | Not Applicable |
Label (PDF)
Letter (PDF) Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/202090Orig1s000ltredt.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2017/202090Orig1_Approval_Pkg.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 07/08/2025 | SUPPL-10 | REMS - MODIFIED - D-N-A |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/202090Orig1s010ltr.pdf |
| 12/08/2023 | SUPPL-6 | REMS - MODIFIED - D-N-A |
Label is not available on this site. |
||
| 01/03/2022 | SUPPL-5 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/03/2022 | SUPPL-4 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/03/2022 | SUPPL-3 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/03/2022 | SUPPL-2 | Labeling-Package Insert |
Label is not available on this site. |
||
| 01/03/2022 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 01/17/2017 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/202090lbl.pdf |